Interleukin-2 (IL-2), Interleukin-5 (IL-5) and Interleukin-17 (IL-17) Levels of Patients With Stainless Steel Crowns

计划入组 12 人 · 首次发布于 2024 年 6 月 3 日

Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis

计划入组 10 人 · 首次发布于 2025 年 2 月 18 日

Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients

计划入组 12 人 · 首次发布于 2024 年 5 月 10 日

DHODH/IL-17 Inhibitors (Incozen Therapeutics)

IL-6 inhibitors (Interprotein/RIKEN)

Interleukin-7

吉林天衡英睿制药有限公司

黑龙江华玺生物医药科技有限公司

江苏开元药业有限公司

Immunology Market Evolution: Interleukin Inhibitors Rise as Biosimilars Reshape Treatment Landscape

Biomarkers Identified to Predict Treatment Response in Psoriatic Arthritis

QuantX Biosciences Raises $85M Series B to Advance Oral STAT6 and IL-17 Inhibitors